| 1 |
Li N, Mao J, Tang H, Zhu L, Tan X, Bi J, Wu H, Chen X, Wang Y. Efficacy and safety of adsorptive granulomonocytapheresis in Chinese patients with ulcerative colitis: A retrospective analysis of 50 cases with focus on factors impacting clinical efficacy. J Clin Apher 2020;35:271-80. [PMID: 32378240 DOI: 10.1002/jca.21787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 2 |
Shah SC, Naymagon S, Cohen BL, Sands BE, Dubinsky MC. There is Significant Practice Pattern Variability in the Management of the Hospitalized Ulcerative Colitis Patient at a Tertiary Care and IBD Referral Center. J Clin Gastroenterol 2018;52:333-8. [PMID: 28009685 DOI: 10.1097/MCG.0000000000000779] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 3 |
Sawada K. Cytapheresis (CAP) with leukocyte removal filter/bead column as one therapeutic option for inflammatory bowel disease. Transfus Apher Sci 2017;56:689-97. [PMID: 28986009 DOI: 10.1016/j.transci.2017.08.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 4 |
Sairenji T, Collins KL, Evans DV. An Update on Inflammatory Bowel Disease. Prim Care. 2017;44:673-692. [PMID: 29132528 DOI: 10.1016/j.pop.2017.07.010] [Cited by in Crossref: 217] [Cited by in F6Publishing: 239] [Article Influence: 36.2] [Reference Citation Analysis]
|
| 5 |
Titus J, Ghimire H, Viennois E, Merlin D, Unil Perera AG. Protein secondary structure analysis of dried blood serum using infrared spectroscopy to identify markers for colitis screening. J Biophotonics 2018;11. [PMID: 28742273 DOI: 10.1002/jbio.201700057] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 6 |
Gionchetti P, Rizzello F, Annese V, Armuzzi A, Biancone L, Castiglione F, Comberlato M, Cottone M, Danese S, Daperno M, D'Incà R, Fries W, Kohn A, Orlando A, Papi C, Vecchi M, Ardizzone S; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease. Dig Liver Dis 2017;49:604-17. [PMID: 28254463 DOI: 10.1016/j.dld.2017.01.161] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 7 |
Titus J, Ghimire H, Viennois E, Merlin D, Perera AGU. Infrared spectroscopy as a screening technique for colitis. SPIE Proceedings 2017. [DOI: 10.1117/12.2264462] [Reference Citation Analysis]
|
| 8 |
Titus J, Viennois E, Merlin D, Unil Perera AG. Minimally invasive screening for colitis using attenuated total internal reflectance fourier transform infrared spectroscopy. J Biophotonics 2017;10:465-72. [PMID: 27094092 DOI: 10.1002/jbio.201600041] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
Hashiguchi K, Takeshima F, Akazawa Y, Matsushima K, Minami H, Machida H, Yamaguchi N, Shiozawa K, Ohba K, Ohnita K, Ichikawa T, Isomoto H, Nakao K. Advantages of fecal lactoferrin measurement during granulocyte and monocyte adsorptive apheresis therapy in ulcerative colitis. Digestion 2015;91:208-17. [PMID: 25823500 DOI: 10.1159/000375301] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 10 |
Jiang XL, Cui HF, Gao J, Fan H. Low-dose Infliximab for Induction and Maintenance Treatment in Chinese Patients With Moderate to Severe Active Ulcerative Colitis. J Clin Gastroenterol 2015;49:582-8. [PMID: 25844841 DOI: 10.1097/MCG.0000000000000319] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 11 |
Sacco R, Tanaka T, Yamamoto T, Bresci G, Saniabadi AR. Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders. Expert Rev Gastroenterol Hepatol 2015;9:327-33. [PMID: 25160857 DOI: 10.1586/17474124.2014.953060] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 12 |
Saniabadi AR, Tanaka T, Ohmori T, Sawada K, Yamamoto T, Hanai H. Treating inflammatory bowel disease by adsorptive leucocytapheresis: A desire to treat without drugs. World J Gastroenterol 2014; 20(29): 9699-9715 [PMID: 25110409 DOI: 10.3748/wjg.v20.i29.9699] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 13 |
Martin ST, Vogel JD. Restorative procedures in colonic crohn disease. Clin Colon Rectal Surg 2013;26:100-5. [PMID: 24436657 DOI: 10.1055/s-0033-1348048] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 14 |
Rubin DT, Mody R, Davis KL, Wang CC. Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease. Aliment Pharmacol Ther 2014;39:1143-55. [PMID: 24697826 DOI: 10.1111/apt.12727] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 15 |
Vu M, Hommes DW. Step-Up Versus Top-Down Therapy in Ulcerative Colitis. Medical Therapy of Ulcerative Colitis 2014. [DOI: 10.1007/978-1-4939-1677-1_42] [Reference Citation Analysis]
|
| 16 |
Thompson-fawcett MW, Mortensen NJ. Crohn's disease. Colorectal Surgery 2014. [DOI: 10.1016/b978-0-7020-4965-1.00010-x] [Reference Citation Analysis]
|
| 17 |
Tanaka T, Sugiyama S, Goishi H, Kajihara T, Akagi M, Miura T. Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications. BMC Gastroenterol. 2013;13:130. [PMID: 23961883 DOI: 10.1186/1471-230x-13-130] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 18 |
Tanaka T, Sugiyama S, Goishi H, Kajihara T, Akagi M, Miura T. Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications. BMC Gastroenterol. 2013;13:130. [PMID: 23961883 DOI: 10.1016/s1873-9946(13)60351-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 19 |
C Leitner G, Worel N, Vogelsang H. Selective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease. Transfus Med Hemother 2012;39:246-52. [PMID: 22969694 DOI: 10.1159/000341801] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 20 |
Autenrieth DM, Baumgart DC. Toxic megacolon. Inflamm Bowel Dis 2012;18:584-91. [PMID: 22009735 DOI: 10.1002/ibd.21847] [Cited by in Crossref: 87] [Cited by in F6Publishing: 83] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 21 |
Yokoyama Y, Fukunaga K, Ikeuchi H, Kamikozuru K, Hida N, Ohda Y, Iimuro M, Yoshida K, Kikuyama R, Kato K, Nagase K, Nakamura S, Miwa H, Matsumoto T. The CD4+CD28null and the regulatory CD4+CD25High T-cell phenotypes in patients with ulcerative colitis during active and quiescent disease, and following colectomy. Cytokine 2011;56:466-70. [PMID: 21802311 DOI: 10.1016/j.cyto.2011.06.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 22 |
Vernia P, D’Ovidio V, Meo D. Leukocytapheresis in the treatment of inflammatory bowel disease: Current position and perspectives. Transfus Apher Sci. 2010;43:227-229. [PMID: 20817610 DOI: 10.1016/j.transci.2010.07.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 23 |
El-Tawil AM. Implications of abnormal pathology in fulminating colitis on the outcome of surgery. Pathophysiology 2011;18:171-4. [PMID: 20692820 DOI: 10.1016/j.pathophys.2010.07.001] [Reference Citation Analysis]
|
| 24 |
Kornbluth A, Sachar DB; Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010;105:501-23; quiz 524. [PMID: 20068560 DOI: 10.1038/ajg.2009.727] [Cited by in Crossref: 899] [Cited by in F6Publishing: 888] [Article Influence: 69.2] [Reference Citation Analysis]
|
| 25 |
Osterman MT, Lichtenstein GR. Ulcerative Colitis. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 2010. [DOI: 10.1016/b978-1-4160-6189-2.00112-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 26 |
Sakuraba A, Motoya S, Watanabe K, Nishishita M, Kanke K, Matsui T, Suzuki Y, Oshima T, Kunisaki R, Matsumoto T, Hanai H, Fukunaga K, Yoshimura N, Chiba T, Funakoshi S, Aoyama N, Andoh A, Nakase H, Mizuta Y, Suzuki R, Akamatsu T, Iizuka M, Ashida T, Hibi T. An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment. Am J Gastroenterol 2009;104:2990-5. [PMID: 19724269 DOI: 10.1038/ajg.2009.453] [Cited by in Crossref: 102] [Cited by in F6Publishing: 107] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 27 |
Hibi T, Sameshima Y, Sekiguchi Y, Hisatome Y, Maruyama F, Moriwaki K, Shima C, Saniabadi AR, Matsumoto T. Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan. Dig Liver Dis 2009;41:570-7. [PMID: 19211314 DOI: 10.1016/j.dld.2008.11.020] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 28 |
Lichtenstein GR, Hanauer SB, Sandborn WJ; Practice Parameters Committee of American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol 2009;104:465-83; quiz 464, 484. [PMID: 19174807 DOI: 10.1038/ajg.2008.168] [Cited by in Crossref: 619] [Cited by in F6Publishing: 618] [Article Influence: 44.2] [Reference Citation Analysis]
|
| 29 |
Cuadrado E, Alonso M, Juan MD, Echaniz P, Arenas JI. Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis. World J Gastroenterol 2008; 14(10): 1521-1527 [PMID: 18330941 DOI: 10.3748/wjg.14.1521] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 30 |
Saniabadi AR, Hanai H, Fukunaga K, Sawada K, Shima C, Bjarnason I, Lofberg R. Therapeutic leukocytapheresis for inflammatory bowel disease. Transfus Apher Sci. 2007;37:191-200. [PMID: 17974479 DOI: 10.1016/j.transci.2007.08.003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 31 |
Gisbert JP, Gomollón F. [Common errors in the management of the seriously ill patient with inflammatory bowel disease]. Gastroenterol Hepatol 2007;30:294-314. [PMID: 17493441 DOI: 10.1157/13101982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 32 |
Hanauer SB, Dassopoulos T. Medical therapy for Crohn’s disease. Inflammatory Bowel Disease: From Bench to Bedside. [DOI: 10.1007/0-387-25808-6_33] [Reference Citation Analysis]
|
| 33 |
Katz JA. Management of inflammatory bowel disease in adults. J Dig Dis 2007;8:65-71. [PMID: 17532817 DOI: 10.1111/j.1443-9573.2007.00287.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 34 |
Grover P, Kamat D. Management of inflammatory bowel disease. Clin Pediatr (Phila) 2007;46:359-64. [PMID: 17475997 DOI: 10.1177/0009922806289837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 35 |
Hanai H. Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis. World J Gastroenterol 2006; 12(47): 7568-7577 [PMID: 17171783 DOI: 10.3748/wjg.v12.i47.7568] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 36 |
Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Andoh A, Tsujikawa T, Fujiyama Y, Mitsuyama K, Sata M, Yamada M, Iwaoka Y, Kanke K, Hiraishi H, Hirayama K, Arai H, Yoshii S, Uchijima M, Nagata T, Koide Y. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2006;4:1502-6. [PMID: 17101300 DOI: 10.1016/j.cgh.2006.08.008] [Cited by in Crossref: 406] [Cited by in F6Publishing: 469] [Article Influence: 23.9] [Reference Citation Analysis]
|
| 37 |
García-López S, Gomollón-García F, Pérez-Gisbert J. Cyclosporine in the treatment of severe attack of ulcerative colitis: a systematic review. Gastroenterol Hepatol. 2005;28:607-614. [PMID: 16373009 DOI: 10.1016/s0210-5705(05)71523-5] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 38 |
Kanai T, Hibi T, Watanabe M. The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease. Expert Opinion on Biological Therapy 2006;6:453-66. [DOI: 10.1517/14712598.6.5.453] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 39 |
Makiyama K, Takeshima F, Hamamoto T. Efficacy of rebamipide enemas in active distal ulcerative colitis and proctitis: a prospective study report. Dig Dis Sci 2005;50:2323-9. [PMID: 16416182 DOI: 10.1007/s10620-005-3055-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 40 |
Pal S, Sahni P, Pande GK, Acharya SK, Chattopadhyay TK. Outcome following emergency surgery for refractory severe ulcerative colitis in a tertiary care centre in India. BMC Gastroenterol. 2005;5:39. [PMID: 16316474 DOI: 10.1186/1471-230x-5-39] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 41 |
Kumar S, Ghoshal UC, Aggarwal R, Saraswat VA, Choudhuri G. Severe ulcerative colitis: prospective study of parameters determining outcome. J Gastroenterol Hepatol 2004;19:1247-52. [PMID: 15482530 DOI: 10.1111/j.1440-1746.2004.03486.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 42 |
Craven M, Simpson JW, Ridyard AE, Chandler ML. Canine inflammatory bowel disease: retrospective analysis of diagnosis and outcome in 80 cases (1995-2002). J Small Anim Pract 2004;45:336-42. [PMID: 15266855 DOI: 10.1111/j.1748-5827.2004.tb00245.x] [Cited by in Crossref: 160] [Cited by in F6Publishing: 171] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 43 |
Chang JC, Cohen RD. Medical management of severe ulcerative colitis. Gastroenterol Clin North Am 2004;33:235-50, viii. [PMID: 15177536 DOI: 10.1016/j.gtc.2004.02.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 44 |
Friedman S. General principles of medical therapy of inflammatory bowel disease. Gastroenterol Clin North Am 2004;33:191-208, viii. [PMID: 15177534 DOI: 10.1016/j.gtc.2004.02.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 45 |
Hanauer SB. Medical therapy for ulcerative colitis 2004. Gastroenterology 2004;126:1582-92. [PMID: 15168369 DOI: 10.1053/j.gastro.2004.02.071] [Cited by in Crossref: 126] [Cited by in F6Publishing: 131] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 46 |
Geboes K, Van Assche G, D??hoore A. Handling the Hot Colon. Pathology Case Reviews 2004;9:97-105. [DOI: 10.1097/01.pcr.0000126994.20059.77] [Reference Citation Analysis]
|
| 47 |
Bullen TF, Hershman MJ. Surgery for inflammatory bowel disease. Hospital Medicine 2003;64:719-723. [DOI: 10.12968/hosp.2003.64.12.2363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 48 |
Sachar DB. Leflunomide in Crohn's disease--the open-label case series and the Texas sharpshooter. J Clin Gastroenterol 2003;37:99-100. [PMID: 12869876 DOI: 10.1097/00004836-200308000-00001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 49 |
Hanauer SB, Dassopoulos T. Medical therapy for Crohn’s disease. Inflammatory Bowel Disease: From Bench to Bedside 2003. [DOI: 10.1007/978-1-4020-3477-0_33] [Reference Citation Analysis]
|
| 50 |
Hanai H, Watanabe F, Takeuchi K, Iida T, Yamada M, Iwaoka Y, Saniabadi A, Matsushita I, Sato Y, Tozawa K, Arai H, Furuta T, Sugimoto K, Bjarnason I. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol 2003;1:28-35. [PMID: 15017514 DOI: 10.1053/jcgh.2003.50005] [Cited by in Crossref: 160] [Cited by in F6Publishing: 162] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 51 |
Hanauer SB, Sandborn W; Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol 2001;96:635-43. [PMID: 11280528 DOI: 10.1111/j.1572-0241.2001.3671_c.x] [Cited by in Crossref: 231] [Cited by in F6Publishing: 210] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 52 |
Wong CK, Yacyshyn BR. Fulminant Ulcerative Colitis. Curr Treat Options Gastroenterol 2000;3:217-26. [PMID: 11097739 DOI: 10.1007/s11938-000-0025-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 53 |
Escartín Muñoz-ortiz P, Escartín Marín P. Criterios de ingreso hospitalario de los pacientes con enfermedad de Crohn. Medicine - Programa de Formación Médica Continuada Acreditado 2000;8:296-297. [DOI: 10.1016/s0304-5412(00)70060-6] [Reference Citation Analysis]
|
| 54 |
Hanauer SB. Induction of remission in ulcerative colitis. Trends in Inflammatory Bowel Disease Therapy 1999 2000. [DOI: 10.1007/978-94-011-4002-7_11] [Reference Citation Analysis]
|
| 55 |
Belaiche J. Traitement médical des colites inflammatoires aiguës graves. Acta Endosc 1999;29:569-575. [DOI: 10.1007/bf03022169] [Reference Citation Analysis]
|
| 56 |
Michetti P, Peppercorn MA. Medical therapy of specific clinical presentations. Gastroenterol Clin North Am 1999;28:353-70, viii. [PMID: 10372272 DOI: 10.1016/s0889-8553(05)70060-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 57 |
Leiper K, London IJ, Rhodes JM. Management of the first presentation of severe acute colitis. Baillieres Clin Gastroenterol 1997;11:129-51. [PMID: 9192065 DOI: 10.1016/s0950-3528(97)90058-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
